Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Nephros (NEPH) over the last 8 years, with Q3 2025 value amounting to $0.03.

  • Nephros' EPS (Weighted Average and Diluted) rose 5000.0% to $0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.14, marking a year-over-year increase of 25555.56%. This contributed to the annual value of $0.01 for FY2024, which is 10465.32% up from last year.
  • According to the latest figures from Q3 2025, Nephros' EPS (Weighted Average and Diluted) is $0.03, which was up 5000.0% from $0.02 recorded in Q2 2025.
  • Over the past 5 years, Nephros' EPS (Weighted Average and Diluted) peaked at $0.05 during Q1 2025, and registered a low of -$0.31 during Q3 2022.
  • Its 4-year average for EPS (Weighted Average and Diluted) is -$0.04, with a median of -$0.02 in 2023.
  • In the last 5 years, Nephros' EPS (Weighted Average and Diluted) skyrocketed by 2500.0% in 2024 and then soared by 35000.0% in 2025.
  • Quarter analysis of 4 years shows Nephros' EPS (Weighted Average and Diluted) stood at -$0.1 in 2022, then skyrocketed by 40.0% to -$0.06 in 2023, then soared by 157.22% to $0.03 in 2024, then fell by 12.62% to $0.03 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at $0.03 for Q3 2025, versus $0.02 for Q2 2025 and $0.05 for Q1 2025.